The Comprehensive Review of the Preventive facet of Fatty Liver Disease under the Paradigm of Unani Medicine
Abstract
The liver, recognized as the largest and most vital organ, plays a central role in maintaining the body’s Hararat-e-Ghariziya (innate heat) according to the Unani system of medicine, which has a rich tradition in diagnosing and treating liver disorders. Fatty Liver Disease (FLD), or hepatic steatosis, is a reversible condition characterized by the abnormal accumulation of triglycerides within liver cells, resulting from various causes such as excessive alcohol consumption, obesity, insulin resistance, and metabolic dysfunction. Both alcoholic and non-alcoholic forms of FLD share similar histopathological features, including micro- and macrovesicular fatty changes, making clinical distinction challenging. Unani medicine attributes such liver imbalances to a disruption in the body’s natural temperament and heat regulation, emphasizing prevention through lifestyle modifications, dietary management, and the use of hepatoprotective herbs. This review provides an integrative perspective on FLD, combining modern medical understanding with classical Unani principles to highlight effective preventive and therapeutic strategies rooted in traditional medicine.
Keywords: Fatty Liver Disease, Hararat-e-Ghariziya, Unani Medicine, Insulin Resistance, Hepatic Steatosis, Preventive Care
Keywords:
Fatty Liver Disease, Hararat-e-Ghariziya, Unani Medicine, Insulin Resistance, Hepatic Steatosis, Preventive CareDOI
https://doi.org/10.22270/jddt.v15i7.7263References
1. Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol, 2006; 290(5): G852–G858.
2. Tabri R. Firdaus-ul-Hikmat (Urdu), Vol. 1 & 2. Lahore: Sheikh Mohammad Bashir & Sons; 1997. p. 206–210.
3. Cleveland E, Bandy A, VanWagner LB. Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Clin Liver Dis (Hoboken), 2018; 11(4): 98–104.
4. Misra A, Soares MJ, Mohan V, Anoop S, Abhishek V, Vaidya R, Pradeepa R. Body fat, metabolic syndrome and hyperglycemia in South Asians. J Diabetes Complications, 2018; 32(11): 1068–1075.
5. National Center for Biotechnology Information. StatPearls – Fatty Liver Disease [Internet]. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441992
6. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 2003; 37(4): 917–923. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC2674744/
7. NY Post. Lack of sleep linked to fatty liver risk, study finds. 2024. Available from: https://nypost.com/2024/04/17/health/lack
8. Wikipedia. Fatty liver disease. Available from: https://en.wikipedia.org/wiki/Fatty_liver_disease
9. Nasiri-Ansari N, et al. Therapeutic potential of herbal medicine in NAFLD. Front Pharmacol, 2020; 11: 603926. Available from: https://www.frontiersin.org/articles/10.3389/fphar.2020.603926/full
10. Mayo Clinic. Nonalcoholic fatty liver disease – Symptoms and causes. Available from: https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567
11. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease: Meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016; 64(1): 73–84.
12. Younossi ZM, et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol, 2018; 15(1): 11–20. https://doi.org/10.1038/nrgastro.2017.109
13. Chalasani N, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the AASLD. Hepatology, 2018; 67(1): 328–357. https://doi.org/10.1002/hep.29367
14. Anderson EL, Howe LD, Jones HE, Higgins JPT, Lawlor DA, Fraser A. Prevalence of NAFLD in children and adolescents: A systematic review and meta-analysis. Pediatrics, 2015; 135(1): e138–e147. https://doi.org/10.1542/peds.2014-0617
15. Ibn Sina. Al-Qanun fi al-Tibb, Vol. 2: On Liver Diseases.
16. Jurjani. Zakhira Khwarizm Shahi, Vol. 3: Liver and Humor Derangement.
17. Zakariya Razi. Kitab al-Hawi: Describes hepatic conditions and metabolic disturbances.
18. Parveen H, Siddiqui MY. Fatty liver disease: A holistic concept. Health Journal of Unani Medicine (HJUM), 2022; 7(3): 20–28. Available from: https://journals.lww.com/hjum/fulltext/2022/07000/fatty_liver_disease__a_holistic_concept
19. Naqvi H. Unani understanding of NAFLD: An integrative perspective. J Complement Integr Med, 2021; 18(4): 867–874. https://www.degruyterbrill.com/document/doi/10.1515/jcim-2021-0296
20. Siddiqui MA. Concept and management of fatty liver disease in Unani medicine vis-a-vis conventional medicine. Available from: https://www.researchgate.net/publication/378342168
21. Razi Z. Kitab Al Hawi, Vol. 7. New Delhi: CCRUM; 2000. p. 47–85. Ibn Zuhr AM. Kitabut Taiseer. New Delhi: CCRUM; 1986. p. 114.
22. Ibn Sina. Al-Qanoon fit-Tib (Urdu Translation by Ghulam Hussain Kantoori), Vol. 3. New Delhi: Idara Kitabul Shifa; 2010. p. 854–864.
23. CCRUM. Unani Mufradat (Single Drugs) In Nutshell, Part I.
24. Unani Pharmacopoeia. Murakkabat (Unani Formulations). Vol. 2. Available from: https://ia600807.us.archive.org/32/items/murakkabatunaniformulation2/murakkabat%20%28unani%20formulation%29-2.pdf
Published
Abstract Display: 780 
PDF Downloads: 598 PDF Downloads: 369 How to Cite
Issue
Section
Copyright (c) 2025 Saleha Hasan , Ammar-Ibne-Anwar , Samreen Farha
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.